.[J] Chinese Pharmaceutical Journal, 2011,V46(24): 1959-1960
��
[1]
American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders[M]. DSM-����1994.[2] SUN D F�� YI M J�� LI Y L. Survey of attention deficit hyperactivity disorder among 6-16 years old children in BinZhou City�� Shandong[J]. Chin Ment Health J(�й�����������־)�� 2009�� 23(11):806-809.[3] COMIER E.Attention deficit��hyperactivity disorder:a review and update [J]. J Pediatr Nurs�� 2008�� 3��5��:345-357.[4] ELIA J��Drug treatment for hyperactive children��therapeutic guidelines [J]. Drugs��1993�� 46:863-871.[5] YAN X P�� ZHENG Y�� CUI Y H. Attention-Deficit��Hyperactivity Disorder and juvenile delinquency [J]. Chin Ment Health J(�й�����������־)�� 2010�� 24(8):609-612.[6] CARLSON C L�� TAMM L�� GAUB M.Gender differences in children with ADHD�� ODD�� and co-occurring ADHD/ODD identified in a school population [J]. J Am Acad Child Adolesc Psychiatry�� 1997�� 36(12):1706-1714.[7] XU T�� ZHOU Y�� WEI H W�� et al. Comparison of atomoxetine and methylphenidate for treating children with attention deficit hyperactivity disorder[J]. Chin J Pract Pediatr(�й�ʵ�ö�����־)�� 2008�� 23(7):499-501.[8] Caballero.Adding 8 weeks of behavioural therapy to atomoxetine does not improve classroom behaviour in children with ADHD[J]. Evid Based Ment Health�� 2011�� 14(3):83.[9] Garnock-Jones KP�� Keating GM.Atomoxetine:a review of its use in attention-deficit hyperactivity disorder in children and adolescents[J]. Paediatr Drugs�� 2009�� 11(3):203-226.[10] Suzanne McCarthy�� Noel Cransweick�� Laura Potts�� et al. Mortality associated with attention-deficit hyperactivity disorder(ADHD) drug treatment[J]. Drug Saf�� 2009�� 32(11):1089-1096.[11] GRAHAM J�� BANASCHEWSKI T�� BUITELAAR J�� et al European guidelines on managing adverse effects of medication for ADHD[J]. Eur child adolesc psychiatry�� 2011�� 20:17-37.
2011, Vol. 46 
